Mersana Therapeutics Statistics
Total Valuation
MRSN has a market cap or net worth of $44.21 million. The enterprise value is -$61.76 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRSN has 124.63 million shares outstanding. The number of shares has increased by 5.54% in one year.
| Current Share Class | 124.63M |
| Shares Outstanding | 124.63M |
| Shares Change (YoY) | +5.54% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 49.29% |
| Float | 79.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.07 |
| Forward PS | 2.12 |
| PB Ratio | -4.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.19
| Current Ratio | 2.19 |
| Quick Ratio | 2.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.93 |
Financial Efficiency
Return on equity (ROE) is -505.14% and return on invested capital (ROIC) is -101.99%.
| Return on Equity (ROE) | -505.14% |
| Return on Assets (ROA) | -24.73% |
| Return on Invested Capital (ROIC) | -101.99% |
| Return on Capital Employed (ROCE) | -89.21% |
| Revenue Per Employee | $397,029 |
| Profits Per Employee | -$678,353 |
| Employee Count | 102 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRSN has paid $418,000 in taxes.
| Income Tax | 418,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.57% in the last 52 weeks. The beta is 1.66, so MRSN's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -90.57% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 44.83 |
| Average Volume (20 Days) | 3,074,998 |
Short Selling Information
The latest short interest is 9.68 million, so 7.77% of the outstanding shares have been sold short.
| Short Interest | 9.68M |
| Short Previous Month | 8.69M |
| Short % of Shares Out | 7.77% |
| Short % of Float | 12.11% |
| Short Ratio (days to cover) | 2.95 |
Income Statement
In the last 12 months, MRSN had revenue of $40.50 million and -$69.19 million in losses. Loss per share was -$0.56.
| Revenue | 40.50M |
| Gross Profit | -32.52M |
| Operating Income | -73.34M |
| Pretax Income | -134.81M |
| Net Income | -69.19M |
| EBITDA | -71.71M |
| EBIT | -73.34M |
| Loss Per Share | -$0.56 |
Full Income StatementBalance Sheet
The company has $134.62 million in cash and $28.65 million in debt, giving a net cash position of $105.97 million or $0.85 per share.
| Cash & Cash Equivalents | 134.62M |
| Total Debt | 28.65M |
| Net Cash | 105.97M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | -9.51M |
| Book Value Per Share | -0.08 |
| Working Capital | 74.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$82.34 million and capital expenditures -$132,000, giving a free cash flow of -$82.47 million.
| Operating Cash Flow | -82.34M |
| Capital Expenditures | -132,000 |
| Free Cash Flow | -82.47M |
| FCF Per Share | -$0.66 |
Full Cash Flow StatementMargins
Gross margin is -80.31%, with operating and profit margins of -181.09% and -170.86%.
| Gross Margin | -80.31% |
| Operating Margin | -181.09% |
| Pretax Margin | -169.82% |
| Profit Margin | -170.86% |
| EBITDA Margin | -177.07% |
| EBIT Margin | -181.09% |
| FCF Margin | n/a |
Dividends & Yields
MRSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.54% |
| Shareholder Yield | n/a |
| Earnings Yield | -156.52% |
| FCF Yield | -186.56% |
Analyst Forecast
The average price target for MRSN is $4.00, which is 1,028.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.00 |
| Price Target Difference | 1,028.03% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 54.29% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MRSN has an Altman Z-Score of -8.18 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.18 |
| Piotroski F-Score | 3 |